@pipeworx/china-disclosures
Connect: https://gateway.pipeworx.io/china-disclosures/mcp · Install: one-click buttons
Tools: 3
Non-SEC Chinese biotech deals and HK/STAR IPO financing — licensing agreements and IPOs with no US-listed party, read straight out of the HKEX and CNINFO exchange disclosure feeds. Keyless.
Tools
hkex_licensing_deals(query?, since?, until?, limit?)— biotech/pharma licensing and collaboration deals disclosed by HKEX-listed companies, including deals with no US-listed party at all (e.g. a Chinese HKEX-listed biotech out-licensing to an Indian, Japanese, or European partner). Sourced from HKEXnews filings titled “License Agreement” or “Licensing Agreement”.hkex_ipo_filings(query?, since?, until?, limit?)— Hong Kong IPO / listing financing filings — the “GLOBAL OFFERING” prospectus and formal notice every company files with HKEX when it lists. Not biotech-specific; filter withquery.cninfo_disclosure_search(query, board?, since?, until?, limit?)— full-text search over CNINFO, the official disclosure feed for both Chinese A-share exchanges (Shenzhen + Shanghai, STAR Market included). Covers A-share-listed companies with zero HK/US nexus — the other half of the gap.
Why this exists, and why china-pharma / pharma-deals don’t already cover it
china_licensing_deals (china-pharma) and pharma_licensing_deals (pharma-deals)
are both SEC 8-K based: they see a deal only if at least one party is US-listed.
A China-to-China or China-to-Japan deal between two companies with no US listing
is real, disclosed, and structurally invisible to either tool. Demand log,
2026-09-13 scouting pass: 3+ real asks for exactly that class of deal, plus
HK/STAR biotech IPO financing.
Two more exchanges’ own disclosure layers close the gap, both probed live 2026-09-13:
- HKEX — any Hong Kong-listed company discloses a material licensing deal or
its own IPO under HKEX listing rules the same day, and HKEXnews’ public
title-search JSON endpoint (
titleSearchServlet.do) serves those filings without a key. This is the same endpointnmpa_drug_approvals(china-pharma) already uses for NMPA approvals — same trick, different title term. - CNINFO (cninfo.com.cn) — the official disclosure feed for SZSE + SSE
A-shares, STAR Market included.
hisAnnouncement/queryis a POST endpoint, no auth, plain browser UA — verified live returning 20,703 matches forsearchkey=许可(license/licence), dated as recent as the day of the probe.
Traps
-
HKEX
titleSearchServlet.doignoresfrom/toentirely whensearchType=1andtitleis set — verified across three different date windows (a 9-month range, a 1-month range, and a single day in 1990) on three different title terms (“License Agreement”, “Licensing Agreement”, “Global Offering”): identical result set every time. It is a rolling most-recent-titles window, not a date-filtered query. Both HKEX tools fetch the unbounded window and applysince/untilthemselves, client-side — a window before the reachable range returnsfound: falsewith an explicit hint naming the actual reachable dates, never a silently-empty “nothing that period”. -
CNINFO’s board/segment filter looks like it should be guessable and isn’t. An initial probe of
category=/plate=kcbfor STAR Market returned HTTP 200 with the full unfiltered result set — a silent no-op, not an error. The real parameter,plate=shkcp, was found by watching the disclosure search page’s OWN network request when its 科创板 (STAR Market) checkbox is selected in the browser — the same recipe china-exchange-data used for SZSE’s report catalogs. Verified as a REAL filter, not another no-op: unfilteredsearchkey=许可returnstotalAnnouncement: 20703;plate=shkcpreturns306, every one of them a 688xxx (STAR Market) code.Unfiltered vs. filtered, same search term, live 2026-09-13:
plate="" (all SZSE+SSE) → totalAnnouncement: 20703 plate="shkcp" (STAR Market) → totalAnnouncement: 306 (all secCode 688xxx)Only
star(shkcp) andchinext(szcy) are exposed asboardvalues — both confirmed the same way. Other segments (main board, GEM) were not observed this way and are deliberately left unmapped rather than guessed; omitboardto search all boards. -
CNINFO’s
seDaterange param genuinely filters server-side (unlike HKEX’sfrom/to) — confirmed by comparing a 12-day window (1 hit) against a disjoint historical month (0 hits) for the identical search term and board. -
Don’t translate a query before searching CNINFO. It is a Chinese full-text index; searching the English translation of a Chinese term returns nothing, and reads as “no disclosures” rather than “wrong language” (see
reference_bilingual_entity_names— never translate-then-search). -
HKEX title search returns duplicate rows for one event. A Global Offering typically produces both a “Listing Documents” row (the prospectus PDF) and an “Announcements and Notices” row (the formal notice) for the same listing — both are returned, tagged with
doc_category, rather than silently deduplicated into one.
Coverage limits, stated honestly
hkex_licensing_deals/hkex_ipo_filings: require the Asian party to be HKEX-listed (Main Board or GEM). A private-to-private deal, or one between two A-share-only companies, is invisible here — usecninfo_disclosure_searchfor the A-share side.cninfo_disclosure_search: requires an A-share-listed party (Shenzhen or Shanghai, including STAR Market). A company listed only overseas (HK, US, or privately held) does not appear.- A deal or listing with neither an HKEX-listed nor an A-share-listed nor an SEC-filing party (china-pharma / pharma-deals) is not visible to any tool in this catalog.
- Both HKEX tools only reach HKEXnews’ current rolling title-search window
(recently, roughly the last several weeks to a couple of months, depending on
how common the phrase is) — see the trap above.
cninfo_disclosure_searchhas no such limit; itssince/untilgenuinely reach back in time.
Auth
None. Keyless on all three tools.
Data sources
hkex_licensing_deals/hkex_ipo_filings:https://www1.hkexnews.hk/search/titleSearchServlet.do(HKEXnews public title search) and the linked filing PDFs underhttps://www1.hkexnews.hk/.cninfo_disclosure_search:https://www.cninfo.com.cn/new/hisAnnouncement/query(CNINFO’s public disclosure search) and PDFs underhttps://static.cninfo.com.cn/.
Tools
- hkex_licensing_deals — Biotech/pharma licensing and collaboration deals disclosed by Hong Kong Exchange (HKEX)-listed companies — covers deals with NO US-listed party at all (e.g. a Chinese HKEX-listed biotech out-licensing
- hkex_ipo_filings — Hong Kong IPO / listing financing filings — the Global Offering prospectus and formal notice every company files with HKEX when it goes public or completes a placement. Answers “recent HK IPOs”, “HKEX
- cninfo_disclosure_search — Full-text search over CNINFO (cninfo.com.cn), the official disclosure feed for BOTH Chinese A-share exchanges — Shenzhen (SZSE) and Shanghai (SSE), STAR Market (科创板) included. Covers A-share-listed co
Tools
-
cninfo_disclosure_search— Full-text search over CNINFO (cninfo.com.cn), the official disclosure feed for BOTH Chinese A-share exchanges — Shenzhen (SZSE) and Shanghai (SSE), STAR Market (科创板) included. Covers A-share-listed co -
hkex_ipo_filings— Hong Kong IPO / listing financing filings — the Global Offering prospectus and formal notice every company files with HKEX when it goes public or completes a placement. Answers recent HK IPOs , HKEX b -
hkex_licensing_deals— Biotech/pharma licensing and collaboration deals disclosed by Hong Kong Exchange (HKEX)-listed companies — covers deals with NO US-listed party at all (e.g. a Chinese HKEX-listed biotech out-licensing